Skip to main content
. 2022 Jun 28;14(13):3169. doi: 10.3390/cancers14133169

Table 5.

Application of TKIs in 22 patients with defined lesions before and after radiotherapy.

Continued TKIs Resistant to 0 TKIs Resistant to 1 TKI Resistant to 2 TKIs Resistant to ≥3TKIs
None 4 1 1
rTKI - 4 4
nTKI - 2 2
sTKI 4 - - -
NA
N 8 6 7 1

Abbreviations: TKIs: tyrosine kinase Inhibitors; rTKI, previously resistant TKIs; nTKI, further lines of TKIs after resistance; sTKI, imatinib in cases in which no TKIs were previously used; NA, not available; N, number.